Range
- - -
Vol / Avg.
-/416.4K
Div / Yield
-
52 Wk
128.7 - 188.14
Mkt Cap
5.4B
Payout Ratio
-
Open
-
P/E
-
EPS
-0.85
Shares
34.8M
Outstanding
34.8M
Total Float
26.5M
Benzinga - Jul 19, 2021, 1:12PM
Benzinga - Jul 19, 2021, 10:10AM
Benzinga - Jul 19, 2021, 10:09AM
Benzinga - Jul 19, 2021, 7:02AM
Benzinga - Jul 9, 2021, 8:30AM
Benzinga - Jul 6, 2021, 6:22AM
Benzinga - Jun 28, 2021, 8:20AM
Benzinga - Jun 28, 2021, 8:11AM
Benzinga - Jun 28, 2021, 7:55AM
Benzinga - Jun 28, 2021, 7:41AM
Benzinga - Jun 22, 2021, 6:04AM
Benzinga - May 6, 2021, 8:41AM
Benzinga - May 5, 2021, 4:46PM
Benzinga - Apr 26, 2021, 8:46AM
Benzinga - Apr 5, 2021, 11:06AM
Benzinga - Feb 26, 2021, 9:02AM
Benzinga - Feb 24, 2021, 4:16PM
Benzinga - Feb 24, 2021, 4:14PM
Benzinga - Feb 2, 2021, 5:59AM
load more
Sector: Health Care.Industry: Health Care Equipment & Supplies
Nevro Corp is a medical device company. Its key product is the Senza spinal cord stimulation system, a neuromodulation platform for the treatment of chronic pain. Senza generates electrical impulses to relieve pain. The system is implanted by physicians and controlled by patients. It consists of leads, a trial stimulator, an implantable pulse generator, surgical tools, a clinician laptop programmer, a patient remote control, and a mobile charger. Nevro generates the majority of its revenue in the United States. It also receives nearly half of its revenue from Australia, the United Kingdom, and Germany.

Earnings

see more
Q2 2021Est.ActualSurprise
EPS
(EXPECTED)2021-08-04
REV
Q1 2021Est.ActualSurprise
EPS-0.840-0.850 -0.0100
REV85.860M88.610M2.750M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
NVRONevro0%5.4B

Nevro Frequently Asked Questions

Q

How do I buy Nevro (NVRO) stock?

A

You can purchase shares of Nevro (NYSE: NVRO) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Nevro's (NVRO) competitors?

A

Other companies in Nevro’s space includes: Heska (NASDAQ:HSKA), Sight Sciences (NASDAQ:SGHT), Masimo (NASDAQ:MASI), Ortho Clinical Diagnostic (NASDAQ:OCDX) and Envista Holdings (NYSE:NVST).

Q

What is the target price for Nevro (NVRO) stock?

A

The latest price target for Nevro (NYSE: NVRO) was reported by Redburn Partners on July 9, 2021. The analyst firm set a price target for 0.00 expecting NVRO to fall to within 12 months (a possible -100.00% downside). 19 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Nevro (NVRO)?

A

The stock price for Nevro (NYSE: NVRO) is $154.56 last updated Thu Jul 29 2021 19:59:59 GMT+0000 (Coordinated Universal Time).

Q

Does Nevro (NVRO) pay a dividend?

A

There are no upcoming dividends for Nevro.

Q

When is Nevro (NYSE:NVRO) reporting earnings?

A
Nevro’s Q2 earnings are confirmed for after-market on August 4, 2021.
Q

Is Nevro (NVRO) going to split?

A

There is no upcoming split for Nevro.

Q

What sector and industry does Nevro (NVRO) operate in?

A

Nevro is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NYSE.